MRVI Stock Summary and Trading Ideas (Maravai Lifesciences Holdings - Class A | NASDAQ:MRVI)

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Maravai Lifesciences Holdings - Class A trades on the NASDAQ stock market under the symbol MRVI.

As of December 19, 2025, MRVI stock price declined to $3.43 with 1,061,232 million shares trading.

MRVI has a beta of 1.86, meaning it tends to be more sensitive to market movements. MRVI has a correlation of 0.20 to the broad based SPY ETF.

MRVI has a market cap of $497.43 million. This is considered a Small Cap stock.

Last quarter Maravai Lifesciences Holdings - Class A reported $42 million in Revenue and -$.08 earnings per share. This fell short of revenue expectation by $-8 million and met earnings estimates .

In the last 3 years, MRVI traded as high as $16.90 and as low as $1.67.

The top ETF exchange traded funds that MRVI belongs to (by Net Assets): VTI, IWM, VXF, IWN, IBB.

MRVI has underperformed the market in the last year with a price return of -36.8% while the SPY ETF gained +18.1%. However, in the short term, MRVI had mixed performance relative to the market. It has outperformed in the last 3 months, returning +27.0% vs +2.8% return in SPY. But in the last 2 weeks, MRVI shares have been beat by the market, returning -7.3% compared to an SPY return of -0.5%.

MRVI support price is $3.39 and resistance is $3.66 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRVI shares will trade within this expected range on the day.